Publication | Closed Access

The benefits of soluble non-bacterial fraction of kefir on blood pressure and cardiac hypertrophy in hypertensive rats are mediated by an increase in baroreflex sensitivity and decrease in angiotensin-converting enzyme activity

HypertensionHeart FailureCardiovascular DiseaseBaroreflex SensitivityMedicineSoluble Non-bacterial FractionPhysiologyAntihypertensive TherapyVascular BiologyCardiovascular PhysiologyMetabolismPharmacologyBlood Pressure